By Larissa Dias
Understanding the Oncology Landscape
Insights, Advancements, and the Role of Market Research
Oncology is evolving fast. Advances like immunotherapies, gene and cell therapies, liquid biopsies, and AI-driven diagnostics are already reshaping cancer care.
But with innovation comes complexity. For pharma and biotech companies, making the right decisions, from early development to market access and launch, requires a clear understanding of this shifting landscape. That’s where market research plays a critical role.
At Med Planet, we help clients navigate this complexity through tailored oncology research. From common cancers to rare, hard-to-reach indications, we deliver meaningful insights using proven qualitative and quantitative approaches.
Precision medicine is reshaping the oncology market
Cancer care is becoming more and more personalised. Advances in biomarker-driven therapies, immuno-oncology, and gene editing are enabling highly targeted treatments.
With this shift, market segmentation becomes more granular. For example, instead of “breast cancer” as a single category, it is now looked at in different forms based on things like hormone levels, certain proteins, or genetic changes. These differences don’t just affect treatment; they also impact how companies plan and launch new products.
To build successful oncology strategies, we need insights that reflect this level of detail.
The challenges of oncology market research
While the need for research has never been greater, conducting it poses several unique challenges:
- Complex and specialised populations: Recruiting oncologists, haematologists, pathologists, or patients with specific tumor profiles often requires niche targeting and global reach.
- Evolving treatment pathways: The standard of care can shift within months. Researchers must adapt to changing landscapes and be prepared to re-field or reframe studies as needed.
- Information overload among HCPs: Oncologists are inundated with clinical data, guidelines, and new product information. Understanding what cuts through and how they process new evidence is key to shaping effective engagement strategies.
- Emotional and psychological dimensions: Understanding the patient journey (including fear, hope, uncertainty, and decision-making) requires empathy and thoughtful methodology.
Capturing these layers demands more than surveys or standard focus groups. It calls for creative approaches, robust screening, and a deep respect for both clinical expertise and patient experience.
How market research supports oncology innovation
If you’re planning oncology research, there are a few critical areas to keep in mind:
- Validate early-stage concepts and unmet needs: Insights from key opinion leaders (KOLs) and frontline oncologists help refine clinical development plans and identify differentiation opportunities.
- Inform access and reimbursement strategies: Payer research clarifies how health systems view value in oncology, a critical concern given the high cost of many therapies.
- Improve patient support and education initiatives: Understanding the real-world barriers patients face, from diagnosis delays to treatment fatigue, helps shape support services that make a difference.
- Reduce risk when launching in competitive or rapidly changing markets: Competitive intelligence, message testing, and tracking studies ensure that new therapies stand out and connect with stakeholders.
Market research doesn’t just support strategy, it shapes it. In oncology, strong insights are key because every decision can affect lives.
The power of emerging data sources
One of the most exciting shifts in oncology research is the growing use of real-world data (RWD) and advanced analytics. Electronic health records (EHRs), claims data, patient registries, and even wearable technologies are being used to track outcomes, monitor safety, and understand treatment patterns beyond the clinical trial setting.
Combined with AI, these data sources can surface trends, predict outcomes, and even identify eligible patient populations for rare biomarker-based studies. However, leveraging RWD requires caution. Data integrity, bias, and representativeness remain key concerns.
That’s where qualitative insight adds value. Numbers can tell us what is happening; speaking with physicians and patients helps us understand why.
Moving forward: Oncology research with purpose
Cancer care will continue to change, driven by science, technology, and the resilience of patients. But innovation on its own isn’t enough.
To ensure therapies reach the right people, at the right time, with the right support, we need clear, useful insights. That means hearing from oncologists making tough choices, patients managing side effects, and healthcare systems trying to deliver care while staying on budget.
At its core, oncology market research is not about reports or metrics. It’s about people. And in a field as complex as cancer, that understanding is more important than ever.
Want to explore how market research can elevate your oncology strategy? Let’s talk about how tailored insights can help you move forward. Contact us today.
Why Med Planet?
At Med Planet, we specialise in custom recruitment, seamless logistics, and regulatory-compliant research execution. Many companies struggle with participant quotas and fail to deliver complete, reliable data, but we ensure every project is executed with precision and efficiency.
